M., Thomas, S
Tirzepatide, better known as Zepbound for weight loss and Mounjaro for treatment of type 2 diabetes, helped patients lose more than 20% of their starting body weight across the reviewed studies
Cold brewed yerba mate provides natural caffeine to help boost energy and sharpen focus
These challenges, intensified by the recent global pandemic, continue to endanger both human and animal health [2]
others may be trying to correct other issues
Tirzepatide May Be a Better Fit If: Maximum weight loss is your primary goal, and tirzepatide consistently produces greater reductions in clinical data You have type 2 diabetes and want superior blood sugar control (SURPASS-2 showed clear superiority over semaglutide) You've tried semaglutide and plateaued, and the dual-agonist mechanism may produce additional response You respond well to lower doses, and tirzepatide 5mg matches semaglutide 2.4mg for weight loss Semaglutide May Be a Better Fit If: Cardiovascular protection is important, as the SELECT trial provides strong evidence for heart benefit You prefer an oral option: oral semaglutide exists (the Ozempic pill for diabetes, which reformulated and renamed Rybelsus in 2026, and the Wegovy pill for weight)